Industry Policy Committee

Purpose: 

To promote initiatives (outside regulatory and reimbursement) which impact on industry development and sustainability and healthcare policy. 

Objectives: 

  1. Develop policy positions and engage with stakeholders on the following:  
  • Digital healthcare agenda including cybersecurity, the electronic patient record, mobile healthcare and registries.
  • Supply chain issues, including traceability of medical devices, and regularly engaged with GS1 Australia. 
  • MTP Connect initiatives, R&D, clinical trials and commercialisation. 
  • Industry input into NSW Knowledge Hun projects to support the MedTech sector. 
  • Industry input into export initiatives and issues. 
  1. Monitor the implementation of the $30 million grant for SMEs under the MTAA‐Government Agreement. 

 

MTAA Secretary: Merrilyn Clancy, Senior Policy Officer

Member Name

Company

Daniel Kildea (Chair)

Johnson & Johnson

Ross Lane

Cook Medical

Matthew Malone

Stryker

Paul Davies

Abbott

Damon Mogridge

Smith+Nephew

Jane Crowe

Roche Diabetes Care Australia

Simon Williamson

Edwards Lifesciences

Rebecca Cortiula

Varian Medical Systems

Kate King

Medtronic

Michael Reynolds

Biotronik

Kirk Kikirekov

Prospitalia h-trak

George Sidis

IDE Group

Geethu Roshan Verghese

Boston Scientific

Naeema Mohamed

Zimmer Biomet

Tansy Michael

Fresenius Medical Care

 

Meeting dates for 2021: 

  • Monday, 1 February
  • Thursday, 18 March
  • Tuesday, 18 May
  • Thursday, 22 July
  • Wednesday, 15 September
  • Monday, 8 November